Figure 1From: The Therapeutic Potential of HDAC Inhibitors in the Treatment of Multiple SclerosisEffects of HDACi on the different cells involved in the pathogenesis of MS. The possible different sites of action of HDACi in the CNS and secondary lymphoid organs are shown. The two arrows from “HDACi” to either “Treg” and “Neuron” indicate promotion of activation (Treg) and survival (neuron). Each of the four lines with a bar on the end indicates inhibition.Back to article page